3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
113
Urinary Bladder Neoplasms
56
Carcinoma, Non-Small-Cell Lung
52
Cholangiocarcinoma
33
Biliary Tract Neoplasms
32
Neoplasm Metastasis
30
Ovarian Neoplasms
27
Lymphoma, Large B-Cell, Diffuse
26
Breast Neoplasms
25
Lung Neoplasms
24
Neoplasms
23
Carcinoma, Transitional Cell
23
Triple Negative Breast Neoplasms
22
Nasopharyngeal Carcinoma
21
Colorectal Neoplasms
20
Recurrence
17
Non-Muscle Invasive Bladder Neoplasms
16
Gallbladder Neoplasms
15
Fallopian Tube Neoplasms
15
Sarcoma
13
Bile Duct Neoplasms
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Hodgkin Disease
10
Lymphoma
9
Uterine Cervical Neoplasms
8
Adenocarcinoma
8
Stomach Neoplasms
7
Lymphoma, Non-Hodgkin
7
Endometrial Neoplasms
7
Nasopharyngeal Neoplasms
6
Interventions
Cyclophosphamide
9
Biopsy
5
Specimen Handling
4
Prednisone
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
fludarabine
3
Vincristine
3
Etoposide
3
Doxorubicin
3
Brentuximab Vedotin
3
sodium-iodide symporter
2
pembrolizumab
2
fludarabine phosphate
2
cemiplimab
2
alectinib
2
X-Rays
2
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Rituximab
2
Positron-Emission Tomography
2
Photons
2
Mycophenolic Acid
2
Immunoglobulin G
2
Filgrastim
2
Disulfides
2
Cyclosporine
2
10-propargyl-10-deazaaminopterin
2
treosulfan
1
talimogene laherparepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Anaplastic
×
Gemcitabine
×
1 year
×
Clear all
No trials found.